Arnold I. Freeman, MD of Roswell Park Memorial Institute
Sessions:
This meeting consisted of a small group of twelve scientific participants. The think tank was divided into three sessions. The first session was chaired by Dr. Lawrence Helson and dealt with current therapy in a far advanced neuroblastoma. The second session was chaired by Dr. John Kemshead and discussed innovative approaches to therapy including new treatments and possible future directions. The third session was chaired by Dr. Garrett Brodeur and discussed control factors in neuroblastoma.
Each session began with a brief case presentation of a patient who had suffered from neuroblastoma. An attempt to translate basic research to actual patient care was made. There were participants from around the world including Japan, Europe and England as well as the United States.
The enthusiasm generated by this meeting was very high among the scientific participants. It was considered that the think tank concept was excellent and of great value. Among the practical spinoffs that resulted from this meeting were:
Robert Bolande, MD
East Carolina School of Medicine
Garrett Brodeur, MD
St. Louis Children's Hospital
Arnold I. Freeman, PhD
Roswell Park Memorial Institute
Lawrence Helson, MD
Memorial Sloan Kettering Cancer Center
Mark A. Isreal, MD
National Cancer Institute
John T. Kemshead, MD
Institute of Child Health
Rajko Medecina, MD, PhD
SCCO
Thierry Phillip, MD
Centre Leon Berard
Patrick Reynolds, MD, PhD
Naval Medical Research Institute
Cameron Tebbi, MD
Roswell Park Memorial Institute
Patrick Thomas, MD
Mallinckrodt Institute of Radiology
J. Uchino, MD
Hokkaido University